Anti-Thyroid Peroxidase Antibody Test Kit Market Revenue to Attain USD 314.28 Mn by 2033

12 Aug 2025

Share :

Table of Content

1. Anti-Thyroid Peroxidase Antibody Test Kit Market Revenue and Trends 2025 to 2033 2. What are the Major Factors Driving the Growth of the Anti-Thyroid Peroxidase Antibody Test Kit Market? 3. Segment Outlook 4. Regional Insights 5. Anti-Thyroid Peroxidase Antibody Test Kit Market Coverage 6. Anti-Thyroid Peroxidase Antibody Test Kit Market Key Players

Anti-Thyroid Peroxidase Antibody Test Kit Market Revenue and Trends 2025 to 2033

The global anti-thyroid peroxidase antibody test kit market revenue surpass USD 162.92 million in 2025 and is predicted to attain around USD 314.28 million by 2033, growing at a CAGR of 8.56%. The growth of the market is driven by the increasing prevalence of thyroid disorders and the growing demand for early, accurate diagnosis.

What are the Major Factors Driving the Growth of the Anti-Thyroid Peroxidase Antibody Test Kit Market?

The market is experiencing significant growth due to the rising global prevalence of autoimmune thyroid disorders, such as Hashimoto's thyroiditis and Graves' disease, alongside growing awareness of early diagnosis. Increased healthcare spending, rapid advancements in diagnostic technology, and the rise of point-of-care testing are boosting market growth. The aging population, coupled with lifestyle-related hormonal imbalances, further propels market growth. Government screening programs, improved lab infrastructure, and the demand for preventive healthcare also influence the growth of the market.

The rising development of accurate, low-cost test kits and rising research funding that facilitates the development of accessible diagnostic tools are opening up new growth avenues. There is a strong emphasis on improving the accuracy of the diagnosis of anti-thyroid peroxidase and autoimmune-related thyroid disorders, especially in low-resource environments where diagnostic access is limited. Moreover, the rising development of advanced technologies, such as multiplex assays and automated testing platforms, creates immense opportunities in the market.

Segment Outlook

• By technology, the enzyme-linked immunosorbent assay (ELISA) segment led the market in 2024, owing to its high adoption, driven by its greater accuracy, sensitivity, and reliability.
• By test type, the quantitative test kits segment sustained dominance in the market in 2024 due to its accurate measurements, which help in early diagnosis and monitoring of diseases for better treatment.
• By sample type, the serum segment dominated the market in 2024, as serum samples provide high accuracy, stability, and more reliable results for diagnoses. 
• By end-user, the diagnostic laboratories segment contributed the largest market share in 2024 due to their advanced, well-developed infrastructure, trained professionals, and the ability to process high-volume tests quickly and accurately.
• By distribution channel, the distributors/ wholesalers segment dominated the market in 2024 due to their well-established supply chains to deliver products. Distributors have established networks across hospitals, diagnostic labs, clinics, and pharmacies, enabling rapid and broad market access.
• By application, the autoimmune thyroid disease diagnosis segment led the market in 2024 due to the increased prevalence of autoimmune thyroid disease. Growing awareness of early disease detection further bolsters segmental growth.

Regional Insights

North America registered dominance in the anti-thyroid peroxidase antibody test kit market in 2024. This dominance stems from its advanced healthcare infrastructure, heightened awareness of thyroid disorders, and the widespread use of preventive test kits. The region's substantial healthcare expenditures, coupled with increased insurance coverage and sophisticated laboratory testing equipment, fuel this growth. The rising incidence of autoimmune thyroid diseases, alongside established screening programs, further supports market expansion. Moreover, the presence of numerous diagnostic companies and research institutions in the region, alongside a commitment to innovation, drives the adoption of these critical products.

Asia Pacific is poised for rapid growth, driven by increased healthcare spending, improved diagnostic facilities, and growing awareness of early thyroid disease detection. Rapid urbanization and lifestyle changes are responsible for autoimmune disorder’s rising prevalence. Governments of countries like China, India, and Japan are investing heavily in screening programs and R&D, boosting the demand for anti-thyroid peroxidase antibody test kits. Moreover, the rising demand for POCT and personalized testing is influencing the market growth in the region.

Anti-Thyroid Peroxidase Antibody Test Kit Market Coverage

Recent Development

• In 2024, Siemens Healthineers expanded its immunoassay portfolio by adding autoimmune thyroid markers, including Anti-TPO, to its Atellica platform. (Source: https://www.siemens-healthineers.com)

Anti-Thyroid Peroxidase Antibody Test Kit Market Key Players

• Thermo Fisher Scientific Inc.
• Abbott Laboratories
• Siemens Healthineers
• Bio-Rad Laboratories, Inc.
• F. Hoffmann-La Roche Ltd.
• Danaher Corporation (Beckman Coulter)
• DiaSorin S.p.A
• Ortho Clinical Diagnostics
• Merck KGaA
• EUROIMMUN AG (a PerkinElmer company)
• Tosoh Corporation
• Biorbyt Ltd
• Abcam plc
• Inova Diagnostics, Inc.
• Seramun Diagnostica GmbH
• Trinity Biotech
• MyBioSource, Inc.
• Creative Diagnostics
• IBL-America
• Biocheck, Inc.

Get this report to explore global market size, share, CAGR, and trends, featuring detailed segmental analysis and an insightful competitive landscape overview @ https://www.precedenceresearch.com/sample/6560

You can place an order or ask any questions, please feel free to contact at sales@precedenceresearch.com |+1 804 441 9344